Saltar al contenido
Merck

Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).

Bioorganic & medicinal chemistry letters (2008-12-23)
Kyle A Emmitte, Brian J Wilson, Erich W Baum, Holly K Emerson, Kevin W Kuntz, Kristen E Nailor, James M Salovich, Stephon C Smith, Mui Cheung, Roseanne M Gerding, Kirk L Stevens, David E Uehling, Robert A Mook, Ganesh S Moorthy, Scott H Dickerson, Anne M Hassell, M Anthony Leesnitzer, Lisa M Shewchuk, Arthur Groy, Jason L Rowand, Kelly Anderson, Charity L Atkins, Jingsong Yang, Peter Sabbatini, Rakesh Kumar
RESUMEN

The optimization of imidazo[1,2-a]pyridine inhibitors as potent and selective inhibitors of IGF-1R is presented. Further optimization of oral exposure in mice is also discussed. Detailed selectivity, in vitro activity, and in vivo PK profiles of an optimized compound is also highlighted.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Imidazo[1,2-a]pyridine, 99%